Skip to content
OpenCapital
Get started

Tectonic Therapeutics TECX AOCI

AOCI at other companies

ALN
Alnylam PharmaceuticalsALNY
-$24.89M+33.6%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$569K-387%
Regenxbio logo
RegenxbioRGNX
-$870K-14.2%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$586K+124%
Opko Health logo
Opko HealthOPK
-$27.49M+38.9%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$1.19M+240%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%—
Debt / equity0×0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's AOCI?
Tectonic Therapeutics (TECX) reported AOCI of $0 in Q1 2026.
How has Tectonic Therapeutics's AOCI changed year-over-year?
Tectonic Therapeutics's AOCI decreased by 100.0% year-over-year, from $2K to $0.
What is the long-term trend for Tectonic Therapeutics's AOCI?
Over 2 years (2023 to 2025), Tectonic Therapeutics's AOCI has grown at a 195.4% compound annual growth rate (CAGR), from -$11K to -$96K.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.